Skip to main content
. 2015 Jul 14;106(8):1033–1040. doi: 10.1111/cas.12713

Figure 5.

Figure 5

Endogenous p53 downregulates CRKL mRNA and protein levels. (a) Cells were treated with adriamycin (ADR, 0.5 μg/mL) for 24 h. CRKL and p53 protein levels were determined by immunoblot analysis. β-actin was included as a loading control. Kiku and U2OS have wild type p53, Saos2 cells are deleted for p53, and HOS cells have mutant p53. (b) CRKL mRNA levels were assessed by real-time RT-PCR. (c) The indicated cells were treated with ADR for 16 h. Relative miRNA expression levels were quantified by real-time RT-PCR.